Policies & Research

Why are a small group of people born immune to hepatitis C?

Virologist Connor Bamford and Professor John McLauchlan, both of the University of Glasgow, explain to the Hepatitis SA Community News how their research shows that not all people are equally …

New guidelines mean more freedom for healthcare workers living with BBVs

New national guidelines endorsed by the Australian Health Ministers’ Advisory Council have been released in January 2019 for healthcare workers who perform exposure-prone procedures, and for healthcare workers living with …
The scene in the street outside Dr Solomon’s Chennai clinic during the floods which disrupted the study

Treating Hepatitis C Under Nearly Impossible Conditions

The challenge of eliminating hepatitis in India...

New Liver Cancer Marker Promises Earlier Diagnosis and Better Outcomes

Australian researchers have found a way to predict the risk of liver cancer in people with chronic hepatitis B, promising earlier diagnosis, better management and potentially better prevention of hepatitis …

The Challenges of Aboriginal Prisoner Care in South Australia

While only 2.3 per cent of South Australia’s population is Indigenous, almost a quarter (22 per cent) of people in the State’s prison system are Aboriginal. The prison population is …

Reaching Out to Baby Boomers

Hepatitis Australia is currently developing a campaign to reach baby boomers and other community groups who may have been missed in past hepatitis C awareness raising efforts. Almost eight out …

Tackling Hepatitis and Other Blood-Borne Viruses in Prisons

The prevalence of hepatitis C and  hepatitis B in Australian prisons is higher than in in the wider community, but prison settings also present and opportunity for testing, monitoring and …

Retirement for Hep B Bear?

The stages of chronic hepatitis B infection has been given a makeover. Is it time for Hep B Bear to move aside? The latest clinical practice guidelines for hepatitis B published by the …

New Improved Hepatitis B Medicine to be Considered for Pharmaceutical Benefits Scheme

As Australians with hepatitis C are being cured at unprecedented rates, there is promise of a better medicine for those living with chronic hepatitis B who need treatment. The Pharmaceutical Benefits Advisory …

AIVL Applauds Greens’ New Drug Policy

The national organisation representing people who use drugs, AIVL has applauded the Australian Greens’ courageous leadership in adopting an evidence-based drug policy that focuses on saving lives. The Australian Greens …

Saliva, Cricket and Viral Diseases – Hysteria Resurfaces

Misinformation has reared its ugly head again as South Australians waded into the debate over the Du Plessis ball tampering drama. The South African cricket captain’s controversial habit of polishing …

Quite Little, Very Late – Government response to Silent Disease Report

The Federal Government’s response to the ‘Silent Disease’ inquiry into hepatitis C in Australia falls well short of what anyone living with hepatitis C could have hoped. Coming nearly 18 months …
Knitted dolls in a shop

Treating Children with HBV – Predictors of Success

A unique longitudinal real life study on entecavir-treated children and adolescents have found that HBV DNA results at six and twelve months after starting treatment, are predictors of viral suppression. Another predictor …

Clinical Trials Find Home at New RAH

Minister for Health, Jack Snelling, has confirmed today that most researchers undertaking existing clinical trials as well as new trials being planned, will be housed within the new Royal Adelaide …